메뉴 건너뛰기




Volumn 98, Issue 5, 2006, Pages 580-584

Usefulness of Anemia in Men as an Independent Predictor of Two-Year Cardiovascular Outcome in Patients Presenting With Acute Coronary Syndrome

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

EID: 33747190399     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.03.031     Document Type: Article
Times cited : (62)

References (9)
  • 1
    • 0036788546 scopus 로고    scopus 로고
    • ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina)
    • Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., Jones R.H., Kereiakes D., Kupersmith J., Levin T.N., et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 106 (2002) 1893-1900
    • (2002) Circulation , vol.106 , pp. 1893-1900
    • Braunwald, E.1    Antman, E.M.2    Beasley, J.W.3    Califf, R.M.4    Cheitlin, M.D.5    Hochman, J.S.6    Jones, R.H.7    Kereiakes, D.8    Kupersmith, J.9    Levin, T.N.10
  • 6
    • 4043099767 scopus 로고    scopus 로고
    • Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial
    • Nikolsky E., Aymong E.D., Halkin A., Grines C.L., Cox D.A., Garcia E., Mehran R., Tcheng J.E., Griffin J.J., Guagliumi G., et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 44 (2004) 547-553
    • (2004) J Am Coll Cardiol , vol.44 , pp. 547-553
    • Nikolsky, E.1    Aymong, E.D.2    Halkin, A.3    Grines, C.L.4    Cox, D.A.5    Garcia, E.6    Mehran, R.7    Tcheng, J.E.8    Griffin, J.J.9    Guagliumi, G.10
  • 7
    • 2542469507 scopus 로고    scopus 로고
    • Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain. results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study
    • Arant C.B., Wessel T.R., Olson M.B., Bairey Merz C.N., Sopko G., Rogers W.J., Sharaf B.L., Reis S.E., Smith K.M., et al. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain. results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol 43 (2004) 2009-2014
    • (2004) J Am Coll Cardiol , vol.43 , pp. 2009-2014
    • Arant, C.B.1    Wessel, T.R.2    Olson, M.B.3    Bairey Merz, C.N.4    Sopko, G.5    Rogers, W.J.6    Sharaf, B.L.7    Reis, S.E.8    Smith, K.M.9
  • 9
    • 0028219835 scopus 로고
    • Hematocrit and the risk of cardiovascular disease-the Framingham study. a 34-year follow-up
    • Gagnon D.R., Zhang T.J., Brand F.N., and Kannel W.B. Hematocrit and the risk of cardiovascular disease-the Framingham study. a 34-year follow-up. Am Heart J 127 (1994) 674-682
    • (1994) Am Heart J , vol.127 , pp. 674-682
    • Gagnon, D.R.1    Zhang, T.J.2    Brand, F.N.3    Kannel, W.B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.